• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Lmo2、Arf 肿瘤抑制因子与 Notch1 在小鼠 T 细胞恶性肿瘤中的功能相互作用。

Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies.

机构信息

Division of Experimental Hematology, Department of Hematology, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.

出版信息

Blood. 2011 May 19;117(20):5453-62. doi: 10.1182/blood-2010-09-309831. Epub 2011 Mar 22.

DOI:10.1182/blood-2010-09-309831
PMID:21427293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3109717/
Abstract

LMO2 is a target of chromosomal translocations in T-cell tumors and was activated by retroviral vector insertions in T-cell tumors from X-SCID patients in gene therapy trials. To better understand the cooperating genetic events in LMO2-associated T-cell acute lymphoblastic leukemia (T-ALL), we investigated the roles of Arf tumor suppressor loss and Notch activation in murine models of transplantation. Lmo2 overexpression enhanced the expansion of primitive DN2 thymocytes, eventually facilitating the stochastic induction of clonal CD4(+)/CD8(+) malignancies. Inactivation of the Arf tumor suppressor further increased the self-renewal capacity of the primitive, preleukemic thymocyte pool and accelerated the development of aggressive, Lmo2-induced T-cell lympholeukemias. Notch mutations were frequently detected in these Lmo2-induced tumors. The Arf promoter was not directly engaged by Lmo2 or mutant Notch, and use of a mouse model in which activation of a mutant Notch allele depends on previous engagement of the Arf promoter revealed that Notch activation could occur as a subsequent event in T-cell tumorigenesis. Therefore, Lmo2 cooperates with Arf loss to enhance self-renewal in primitive thymocytes. Notch mutation and Arf inactivation appear to independently cooperate in no requisite order with Lmo2 overexpression in inducing T-ALL, and all 3 events remained insufficient to guarantee immediate tumor development.

摘要

LMO2 是 T 细胞肿瘤中染色体易位的靶标,并且在 X-SCID 患者的基因治疗试验中的 T 细胞肿瘤中通过逆转录病毒载体插入而被激活。为了更好地理解 LMO2 相关 T 细胞急性淋巴细胞白血病(T-ALL)中合作的遗传事件,我们在移植小鼠模型中研究了 Arf 肿瘤抑制基因缺失和 Notch 激活的作用。Lmo2 的过表达增强了原始 DN2 胸腺细胞的扩增,最终促进了克隆性 CD4(+)/CD8(+)恶性肿瘤的随机诱导。Arf 肿瘤抑制基因的失活进一步增加了原始、白血病前期胸腺细胞池的自我更新能力,并加速了侵袭性、由 Lmo2 诱导的 T 细胞淋巴白血病的发展。在这些由 Lmo2 诱导的肿瘤中经常检测到 Notch 突变。Arf 启动子未被 Lmo2 或突变型 Notch 直接结合,并且使用一种依赖于 Arf 启动子先前结合来激活突变型 Notch 等位基因的小鼠模型表明 Notch 激活可能作为 T 细胞肿瘤发生的后续事件发生。因此,Lmo2 与 Arf 缺失合作以增强原始胸腺细胞中的自我更新。 Notch 突变和 Arf 失活似乎与 Lmo2 过表达独立地合作,在诱导 T-ALL 中不需要特定的顺序,并且所有 3 个事件仍然不足以保证立即发生肿瘤发展。

相似文献

1
Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies.Lmo2、Arf 肿瘤抑制因子与 Notch1 在小鼠 T 细胞恶性肿瘤中的功能相互作用。
Blood. 2011 May 19;117(20):5453-62. doi: 10.1182/blood-2010-09-309831. Epub 2011 Mar 22.
2
Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia.Notch1 驱动的 T 细胞急性淋巴细胞白血病起始和进展过程中 Ink4a-Arf(Cdkn2a)肿瘤抑制基因座的表观遗传调控。
Exp Hematol. 2013 Apr;41(4):377-86. doi: 10.1016/j.exphem.2012.11.006. Epub 2012 Nov 23.
3
Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.Notch1 抑制靶向 Tal1/Lmo2 小鼠模型 T-ALL 中的白血病起始细胞。
Blood. 2011 Aug 11;118(6):1579-90. doi: 10.1182/blood-2010-08-300343. Epub 2011 Jun 13.
4
The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal.Lmo2 癌基因通过诱导胸腺细胞自我更新引发小鼠白血病。
Science. 2010 Feb 12;327(5967):879-83. doi: 10.1126/science.1182378. Epub 2010 Jan 21.
5
Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell acute lymphoblastic leukemia.Ldb1 对于 Lmo2 癌基因诱导的胸腺细胞自我更新和 T 细胞急性淋巴细胞白血病是必需的。
Blood. 2020 Jun 18;135(25):2252-2265. doi: 10.1182/blood.2019000794.
6
A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.一个先前未被识别的 LMO2 启动子构成了介导部分 T 急性淋巴细胞白血病患者 LMO2 表达的转录调控回路的一部分。
Oncogene. 2010 Oct 28;29(43):5796-808. doi: 10.1038/onc.2010.320. Epub 2010 Aug 2.
7
Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia.Notch1诱导的T细胞急性淋巴细胞白血病中Arf基因的阶段特异性肿瘤抑制作用
Blood. 2009 Nov 12;114(20):4451-9. doi: 10.1182/blood-2009-07-233346. Epub 2009 Sep 16.
8
Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.尽管存在 PTEN 和 INK4A/ARF 的缺失,急性 T 细胞白血病仍然依赖于 Notch 信号通路。
Blood. 2010 Feb 11;115(6):1175-84. doi: 10.1182/blood-2009-04-214718. Epub 2009 Dec 11.
9
A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.TAL1 的一个 DNA 结合突变体与 LMO2 协同作用导致小鼠 T 细胞白血病。
Oncogene. 2011 Mar 10;30(10):1252-60. doi: 10.1038/onc.2010.495. Epub 2010 Nov 8.
10
Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.Lyl1 在 Lmo2 驱动的早期 T 细胞前体 ALL 模型中的需求。
Blood. 2013 Sep 19;122(12):2093-103. doi: 10.1182/blood-2012-09-458570. Epub 2013 Aug 7.

引用本文的文献

1
Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition.Lmo2 的过表达通过损害胸腺细胞竞争引发 T 淋巴细胞性白血病。
J Exp Med. 2023 Jun 5;220(6). doi: 10.1084/jem.20212383. Epub 2023 Mar 15.
2
Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis.ARF 肿瘤抑制因子在发育和肿瘤发生中的非规范功能。
Biomolecules. 2021 Jan 12;11(1):86. doi: 10.3390/biom11010086.
3
The Yin and Yang-Like Clinical Implications of the Gene Cluster in Acute Lymphoblastic Leukemia.急性淋巴细胞白血病基因簇的阴阳似临床意义。
Genes (Basel). 2021 Jan 9;12(1):79. doi: 10.3390/genes12010079.
4
Lmo2 expression defines tumor cell identity during T-cell leukemogenesis.Lmo2 表达在 T 细胞白血病发生过程中定义肿瘤细胞特性。
EMBO J. 2018 Jul 13;37(14). doi: 10.15252/embj.201798783. Epub 2018 Jun 7.
5
Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes.基于培养胸腺细胞中插入性致癌基因激活和分化阻滞评估逆转录病毒载体的安全性
Mol Ther. 2016 Jun;24(6):1090-1099. doi: 10.1038/mt.2016.55. Epub 2016 Mar 9.
6
The LMO2 oncogene regulates DNA replication in hematopoietic cells.LMO2致癌基因调节造血细胞中的DNA复制。
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1393-8. doi: 10.1073/pnas.1515071113. Epub 2016 Jan 13.
7
Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development.JAK2突变对T细胞淋巴母细胞淋巴瘤发生发展的作用。
Leukemia. 2016 Jan;30(1):94-103. doi: 10.1038/leu.2015.202. Epub 2015 Jul 28.
8
Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary disease.miR-146a单核苷酸多态性对慢性阻塞性肺疾病吸烟者COX-2蛋白表达及肺功能的影响
Int J Chron Obstruct Pulmon Dis. 2015 Mar 4;10:463-73. doi: 10.2147/COPD.S74345. eCollection 2015.
9
Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice.Hhex 通过调节 Kit 促进 Lmo2 转基因小鼠自我更新的胸腺细胞的放射抗性。
Leukemia. 2015 Apr;29(4):927-38. doi: 10.1038/leu.2014.292. Epub 2014 Oct 6.
10
Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.Prdm16 mRNA 的下调是 HOXB4 介导的体内 HSC 扩增过程中的一种特异性抗白血病机制。
Blood. 2014 Sep 11;124(11):1737-47. doi: 10.1182/blood-2013-10-534735. Epub 2014 Jul 31.

本文引用的文献

1
The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal.Lmo2 癌基因通过诱导胸腺细胞自我更新引发小鼠白血病。
Science. 2010 Feb 12;327(5967):879-83. doi: 10.1126/science.1182378. Epub 2010 Jan 21.
2
Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia.Notch1诱导的T细胞急性淋巴细胞白血病中Arf基因的阶段特异性肿瘤抑制作用
Blood. 2009 Nov 12;114(20):4451-9. doi: 10.1182/blood-2009-07-233346. Epub 2009 Sep 16.
3
The Ink4/Arf locus is a barrier for iPS cell reprogramming.Ink4/Arf基因座是诱导多能干细胞重编程的一个障碍。
Nature. 2009 Aug 27;460(7259):1136-9. doi: 10.1038/nature08290. Epub 2009 Aug 9.
4
Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.在Lmo2处有逆转录病毒插入的小鼠白血病可预测逆转录病毒基因治疗后SCID-X1患者诱发的白血病。
PLoS Genet. 2009 May;5(5):e1000491. doi: 10.1371/journal.pgen.1000491. Epub 2009 May 22.
5
Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice.Arf-Cre报告基因小鼠雄性生殖细胞和眼睛发育过程中Arf肿瘤抑制因子的瞬时表达。
Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6285-90. doi: 10.1073/pnas.0902310106. Epub 2009 Apr 1.
6
The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.造血作用及BCR-ABL诱导的白血病中的INK4-ARF(CDKN2A/B)基因座
Cold Spring Harb Symp Quant Biol. 2008;73:461-7. doi: 10.1101/sqb.2008.73.039. Epub 2008 Nov 21.
7
Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression.通过降低p16Ink4a和p19Arf的表达,Hmga2促进幼龄而非老龄小鼠神经干细胞的自我更新。
Cell. 2008 Oct 17;135(2):227-39. doi: 10.1016/j.cell.2008.09.017.
8
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.插入诱变与获得性体细胞突变相结合导致了SCID-X1患者基因治疗后的白血病发生。
J Clin Invest. 2008 Sep;118(9):3143-50. doi: 10.1172/JCI35798.
9
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.4例X连锁重症联合免疫缺陷病(SCID-X1)患者在逆转录病毒介导的基因治疗后发生插入性致癌作用。
J Clin Invest. 2008 Sep;118(9):3132-42. doi: 10.1172/JCI35700.
10
Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia.白血病相关的NOTCH1等位基因是弱肿瘤起始因子,但会加速K-ras引发的白血病。
J Clin Invest. 2008 Sep;118(9):3181-94. doi: 10.1172/JCI35090.